Special in-depth research, surveys and analysis complied into focussed reports with specific stock recommendations. These 12-24 page reports include individual BUY/SELL recommendations from inside and outside our coverage universe, sector analysis, company comparisons, commentary, and more. Individual reports can be purchased below. Small-Cap Growth Stocks and Dividend Growth Stocks. Clients receive individual recommendations, use their own discount brokerage, and build portfolios using our focussed diversification strategy.
Please Note: All VIP Clients receive all “Special Reports” with their annual subscriptions for no additional cost. All annual Canadian Growth Stock Clients receive all “Canadian Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual Income Stock clients receive all “Income/Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual U.S. Growth Stock clients receive all “U.S. Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual TFSA clients receive all “TFSA Related Special Reports” with their annual subscriptions for no additional cost.
KeyStone’s 2022 Roth Conference Update Report$599.00 Add to cart
Recently, KeyStone analysts attended the 34th Annual ROTH Conference in California which included just under 500 publicly traded companies. Prior to the event, our analysts reviewed each attending company and screened the group with our growth-at-a-reasonable-price (GARP) model. Approximately 24 met a threshold of our model and we scheduled in person interviews with management teams from each company. Within this report we have provided statistical analysis on each company as well as summary Monitor reports on a number of companies we are monitoring from the event and Company Update reports on companies that we interviewed and are currently in coverage. While the research did not produce any new recommendations, we uncovered a number of interesting businesses that may enter our BUY coverage over the course of the next 12-months.
KeyStone’s 2022 Cash Rich Profitable Small-Cap Special Report$599.00 Add to cart
KeyStone’s Cash Rich KeyStone’s 2022 Cash Rich, Profitable Canadian Small-Cap Special Report provides clients access to statistical data and additional analysis of 94 stocks that were pulled from over 3,500 in Canada in the course of our research into small-cap companies with strong balance sheets and current profitability from operations. The report includes 5 Cash Rich Recommendations from our Canadian Small-Cap Focus BUY Portfolio and 3 Recommendations from our Canadian Small-Cap Discovery Small-Cap Portfolio. We have included updates on 7 companies which currently rank as HOLD from our current coverage that made the list of 94 as well as 10 Cash Rich Canadian Small-Cap Top Tier Monitor List stocks that we are monitoring closely.
KeyStone’s 2022 Canadian Dividend All-Star Report$599.00 Add to cart
KeyStone’s 2022 Canadian Dividend All-Star Report is a comprehensive analysis of the complete universe of dividend stocks in the Canadian market. We identified approximately 400 dividend-paying stocks listed in Canada and applied KeyStone’s rigorous criteria to find the companies that provide the best value to investors. This report contains our current Focus BUY portfolio (comprised of what we consider to be the top 18 income stocks on the Canadian market) and data on an additional 62 stocks from our Monitor List.
NASDAQ Under $2 Billion Small-Cap Market Report$599.00 Add to cart
This special US Research report individually reviewed approximately 3,500 NASDAQ (primarily) listed stocks with market caps under US$2 billion. The impetus of the project was to get a better understanding of current valuations, increase our analyst’s general knowledge of this set of companies and create a group of over 100 companies which have a threshold level of the GARP or growth at a reasonable price criterion we use to identify near and long-term investment opportunities.
The research produced a list of just over 130 stocks which we have provided statistical analysis on in the tables section. From these initial numbers and our initial review of the businesses, we produced a list of 38 stocks which we provide mini reports on detailing the businesses, current valuations, and merits as potential recommendations.
KeyStone’s 2021 Canadian Cannabis Report$599.00 Add to cart
KeyStone has reviewed the public North American Cannabis market since inception. At legalization in Canada, we rejected all candidates as uninvestable due to a lack of profitability, high valuations and a significant production capacity overbuild. Over the ensuing year, Cannabis stocks across the board plummeted. In late 2019, a very select number of U.S. operating Cannabis stocks had emerged into profitability and one name finally met our criteria. The stock was recommended at $15.99 and reiterated less than a month later at $13.35 as a SPEC BUY. We have since added two smaller Cannabis operators in the U.S. market. We continued to monitor players with operations primarily in the Canadian market but broadly speaking the operational struggles continued. Within this report we conduct statistical analysis on 31 Canadian Cannabis Operators, break down 8-10 of the businesses in more detail and make 3 recommendations in the U.S. Cannabis space.
KeyStone’s U.S. Dividend Growth Stock Special Report$599.00 Add to cart
KeyStone’s Fall 2020 LD Micro 500 Conference Report$599.00 Add to cart
KeyStone’s 2020 Canadian Green/Alternative Energy Stock Report$599.00 Add to cart